UCLA Researchers find cryotherapy as an effective treatment for men with intermediate-risk prostate cancer July 1, 2020 UCLA researchers have found that hemi-gland cryoablation, or cryotherapy, is an effective, primary treatment for men with clinically-significant, or grade 2, prostate cancer. Cryotherapy is a centuries-old technique that uses extremely cold temperatures to freeze and kill cancer cells.Read the full article here.Source: UCLA Health Prostate Cancer News
UCLA researchers have found that hemi-gland cryoablation, or cryotherapy, is an effective, primary treatment for men with clinically-significant, or grade 2, prostate cancer. Cryotherapy is a centuries-old technique that uses extremely cold temperatures to freeze and kill cancer cells.Read the full article here.Source: UCLA Health
Donate Now
